Literature DB >> 8864433

Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.

S B Mossad1, D L Longworth, M Goormastic, J M Serkey, T F Keys, B J Bolwell.   

Abstract

The objective of this study was to define the incidence, type and timing of early infectious complications, occurring within the first 30 days, in autologous bone marrow transplant (autoBMT) recipients over a 45-month period, and in addition to assess the effects of growth factors and primed peripheral blood progenitor cells on the rate of infectious complications. The paper describes a retrospective and observational study, carried out at the bone marrow transplantation unit at a tertiary referral center. The subjects were two hundred and nineteen patients who underwent autologous bone marrow transplantation for a variety of indications from April 1989 to December 1992. The median duration of neutropenia after autologous bone marrow transplantation was 12 days. There was a direct correlation between the duration of neutropenia and the incidence of infectious complications. The overall incidence of infections and isolated febrile episodes was 35%. Septicemia occurred in 7.8% of patients, pneumonia in 2.7%, skin infection in 1.8%, other infections in 2.7% and isolated febrile episodes in 20.1%. Viridans streptococci were the most common cause of septicemia. Invasive fungal infections occurred in only 2.3% of patients. There were no documented viral infections. The use of growth factors and primed peripheral blood progenitor cells was associated with a shorter duration of neutropenia; a decrease in the overall incidence of infections, particularly septicemia and fungal infections; a shorter length of stay in the hospital and a lower mortality rate in the first 30 days after transplantation. We found a lower incidence of bacterial and fungal infections compared to previous studies. The critical factor associated with the occurrence of any early infection was the duration of neutropenia, which was significantly shortened by the use of growth factors and peripheral blood progenitor cells. Septicemia was uncommon in our population and viridans streptococci were the most common bloodstream isolates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864433

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  16 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in Korea.

Authors:  K Moeremans; L Annemans; Ji-So Ryu; Kang-Won Choe; Wan-Shik Shine
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

3.  Early infections after autologous transplantation for haematological malignancies.

Authors:  I Schiødt; O J Bergmann; H E Johnsen; N E Hansen
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

4.  Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.

Authors:  Heather Landau; Kevin Wood; David J Chung; Guenther Koehne; Nikoletta Lendvai; Hani Hassoun; Alexander Lesokhin; Elizabeth Hoover; Junting Zheng; Sean M Devlin; Sergio Giralt
Journal:  Leuk Lymphoma       Date:  2016-01-12

Review 5.  Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.

Authors:  Carolyn D Alonso; Kieren A Marr
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

6.  The predictive value for pulmonary infection by area over the neutrophil curve (D-index) in patients who underwent reduced intensity hematopoietic stem cell transplantation.

Authors:  Jun Aoki; Masaharu Tsubokura; Kazuhiko Kakihana; Gaku Oshikawa; Takeshi Kobayashi; Noriko Doki; Hisashi Sakamaki; Kazuteru Ohashi
Journal:  Pathol Oncol Res       Date:  2014-04-05       Impact factor: 3.201

7.  The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience.

Authors:  B S Sohn; D H Yoon; S Kim; K Lee; E H Kang; J S Park; D H Lee; S H Kim; J Huh; C Suh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-04       Impact factor: 3.267

8.  Incidence and outcomes of Clostridium difficile-associated disease in hematopoietic cell transplant recipients.

Authors:  Achuta Kumar Guddati; Gagan Kumar; Shahryar Ahmed; Muhammad Ali; Nilay Kumar; Parameswaran Hari; Nanda Venu
Journal:  Int J Hematol       Date:  2014-04-09       Impact factor: 2.490

9.  Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.

Authors:  Teruhito Yoshitaka; Mizuho Kittaka; Shu Ishida; Noriyoshi Mizuno; Tomoyuki Mukai; Yasuyoshi Ueki
Journal:  Bone       Date:  2014-10-31       Impact factor: 4.398

10.  A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation.

Authors:  Noemí Puig; Javier de la Rubia; Isidro Jarque; Miguel Salavert; Pau Montesinos; Jaime Sanz; Guillermo Martín; Guillermo Sanz; Susana Cantero; Ignacio Lorenzo; Miguel A Sanz
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.